Acuta Capital Partners, LLC Acadia Pharmaceuticals Inc Transaction History

Acuta Capital Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $930,215 - $1.95 Million	71,500 New	71,500 $1.01 Million
Q1 2018 May 15, 2018	SELL	$22.47 - $32.33 $2.02 Million - $2.91 Million	-90,000 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$26.84 - $39.14 $2.15 Million - $3.13 Million	-80,000 Reduced 47.06%	90,000 $2.71 Million
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $5.01 Million - $6.52 Million	170,000	170,000 $6.4 Million

288

161M

723K

257K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.54B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.